Ignite Health Hires Brian Lefkowitz as Chief Creative Officer

IRVINE, Calif., July 12, 2011 /PRNewswire/ -- Ignite Health, an inVentiv Health company, and a new breed of healthcare agency combining best-in-class branding with first-in-class digital innovation, recently hired Brian Lefkowitz as Chief Creative Officer. Lefkowitz will be responsible for leading all creative efforts as well as building a unified creative structure for the agency's East and West coast offices.

"Brian adds an enormous depth of creative experience to our team," said Matt Brown, president of Ignite Health. "As one of the top creative talents in the industry, with a unique mix of skills and creative leadership credentials, Brian brings both big-idea thinking and a deep knowledge of the digital arena. We're thrilled to have him with us and look forward to the value his new role provides to our current and future clients."

Lefkowitz has more than 17 years of advertising and marketing experience, most recently serving as Senior Vice President, Creative Director at Digitas Health, for clients like Pfizer, Novartis, Medimunne and Sanofi. Prior to Digitas Health, Lefkowitz led creative efforts on the American Express, Nike, Delta and Converse accounts as Vice President, Group Creative Director at Digitas, and also spent 13 years at Grey Worldwide, most recently in the role of Vice President, Creative Director.

In addition to his vast healthcare and consumer experience, Lefkowitz's career has been filled with award-winning creative. Lefkowitz has won Addy's, Effie's, London International Awards, AdWeek awards, Ad Age Awards, MM&M Awards, as well as Mobius and One Show mentions. In his most recent role at Digitas Health, Lefkowitz won numerous honors including awards for the Med Ad News 2011 Best Patient Interactive Campaign and the 2011 Best Consumer Campaign.

About Ignite Health

Headquartered in Irvine, California, Ignite Health is a new breed of healthcare advertising agency with a fresh approach to healthcare marketing and communications. By complementing highly focused print strategies with a wide range of tailored digital strategies – from online advertising and patient education to custom-engineered games and simulations – the company offers clients a broad range of fundamental best practices and digital excellence to create unstoppable momentum for brand success across the continuum of a brand's lifecycle. For more information, visit www.ignitehealth.com.

About inVentiv Health

inVentiv Health, Inc. is a leading global provider of results-driven clinical, consulting and commercial services to the pharmaceutical and healthcare industries.  inVentiv's client roster includes more than 400 pharmaceutical, biotech and life sciences companies.  inVentiv Health Inc. is privately owned by inVentiv Group Holdings Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team.  For more information, visit www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: our ability to sufficiently increase our revenues and maintain or decrease expenses and cash capital expenditures to permit us to fund our operations; our ability to continue to comply with the covenants and terms of our credit facility and to access sufficient capital to fund our operations; our ability to grow our existing client relationships, obtain new clients and cross-sell our services; our ability to successfully operate new lines of business; our ability to manage our infrastructure and resources to support our growth; our ability to successfully identify new businesses to acquire, conclude acquisition negotiations and integrate the acquired businesses including the pending acquisitions of i3 and Pharmanet into our operations; any disruptions, impairments, or malfunctions affecting software as well as excessive costs or delays that may adversely impact our continued investment in and development of software; the potential impact of government regulation on us and on our clients base; our ability to comply with all applicable laws as well as our ability to successfully implement from a timing and cost perspective any changes in applicable laws; our ability to recruit, motivate and retain qualified personnel, including sales representatives; the actual impact of the adoption of certain accounting standards; our ability to maintain technological advantages in a variety of functional areas, including sales force automation, electronic claims surveillance and patient compliance; changes in trends in the healthcare and pharmaceutical industries or in pharmaceutical outsourcing; and our inability to determine the actual time at which the liquidation of the Columbia Strategic Cash Portfolio will be completed or the total losses that we will actually realize from that investment vehicle. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.

SOURCE Ignite Health